Research progress of idiopathic inflammatory demyelinating diseases

Idiopathic inflammatory demyelinating diseases (IIDDs) belongs to autoimmune diseases of nervous system, which is a group of spectrum disorders including multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSDs), acute disseminated encephalomyelitis (ADEM) and other related diseases....

Full description

Bibliographic Details
Main Authors: Xiao-nan ZHONG, Xue-qiang HU
Format: Article
Language:English
Published: Tianjin Huanhu Hospital 2018-02-01
Series:Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:
Online Access:http://www.cjcnn.org/index.php/cjcnn/article/view/1730
id doaj-7d5b0ce4f9f94b44a065b4b2bc4ad9b3
record_format Article
spelling doaj-7d5b0ce4f9f94b44a065b4b2bc4ad9b32020-11-24T23:36:35ZengTianjin Huanhu HospitalChinese Journal of Contemporary Neurology and Neurosurgery1672-67312018-02-01182991091690Research progress of idiopathic inflammatory demyelinating diseasesXiao-nan ZHONG0Xue-qiang HU1Department of Neurology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, Guangdong, ChinaDepartment of Neurology, the Third Affiliated Hospital, Sun Yat-sen University, Guangzhou 510630, Guangdong, ChinaIdiopathic inflammatory demyelinating diseases (IIDDs) belongs to autoimmune diseases of nervous system, which is a group of spectrum disorders including multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSDs), acute disseminated encephalomyelitis (ADEM) and other related diseases. It often occurs in young adults, and the course is relapse-remitting, often leaving neurological sequelae in each episode, and ultimately leading to nerve dysfunction. Early diagnosis, close disease monitoring and prompt treatment are the keys to improve the long-term prognosis of patients. During the period of Twelfth Five-Year Plan for National Economic and Social Development, our team devoted ourselves to the studies of IIDDs and achieved results in the etiology, pathogenesis, clinical features, diagnosis and differential diagnosis, and treatment strategies of the disease respectively. In this paper, we briefly review the above research findings. DOI: 10.3969/j.issn.1672-6731.2018.02.005http://www.cjcnn.org/index.php/cjcnn/article/view/1730Demyelinating diseasesChinaReview
collection DOAJ
language English
format Article
sources DOAJ
author Xiao-nan ZHONG
Xue-qiang HU
spellingShingle Xiao-nan ZHONG
Xue-qiang HU
Research progress of idiopathic inflammatory demyelinating diseases
Chinese Journal of Contemporary Neurology and Neurosurgery
Demyelinating diseases
China
Review
author_facet Xiao-nan ZHONG
Xue-qiang HU
author_sort Xiao-nan ZHONG
title Research progress of idiopathic inflammatory demyelinating diseases
title_short Research progress of idiopathic inflammatory demyelinating diseases
title_full Research progress of idiopathic inflammatory demyelinating diseases
title_fullStr Research progress of idiopathic inflammatory demyelinating diseases
title_full_unstemmed Research progress of idiopathic inflammatory demyelinating diseases
title_sort research progress of idiopathic inflammatory demyelinating diseases
publisher Tianjin Huanhu Hospital
series Chinese Journal of Contemporary Neurology and Neurosurgery
issn 1672-6731
publishDate 2018-02-01
description Idiopathic inflammatory demyelinating diseases (IIDDs) belongs to autoimmune diseases of nervous system, which is a group of spectrum disorders including multiple sclerosis (MS), neuromyelitis optica spectrum disorders (NMOSDs), acute disseminated encephalomyelitis (ADEM) and other related diseases. It often occurs in young adults, and the course is relapse-remitting, often leaving neurological sequelae in each episode, and ultimately leading to nerve dysfunction. Early diagnosis, close disease monitoring and prompt treatment are the keys to improve the long-term prognosis of patients. During the period of Twelfth Five-Year Plan for National Economic and Social Development, our team devoted ourselves to the studies of IIDDs and achieved results in the etiology, pathogenesis, clinical features, diagnosis and differential diagnosis, and treatment strategies of the disease respectively. In this paper, we briefly review the above research findings. DOI: 10.3969/j.issn.1672-6731.2018.02.005
topic Demyelinating diseases
China
Review
url http://www.cjcnn.org/index.php/cjcnn/article/view/1730
work_keys_str_mv AT xiaonanzhong researchprogressofidiopathicinflammatorydemyelinatingdiseases
AT xueqianghu researchprogressofidiopathicinflammatorydemyelinatingdiseases
_version_ 1725522880607813632